Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Peace of Green, Inc.

Active

State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Peace of Green, Inc. is authorized to operate a Manufacturing Type 6 Non-volatile Solvent Extraction license at 1155 E Pico Blvd., Los Angeles, CA 90021. The project scope encompasses non-volatile manufacturing, cultivation, retail sales, and the distribution of commercial cannabis products in compliance with state and local laws. The facility is situated on a lot approximately 148 feet deep and 40 feet wide, utilizing an existing industrial building. The project is classified as categorically exempt under Class 1, as it involves only minor interior improvements with no changes beyond the existing use of the property. Water and electricity services are provided by the City of Los Angeles. This action was initiated through the Department of Cannabis Control, with the primary point of contact being Environmental Scientist Tia Heu.

General Info

Peace of Green operates compliant cannabis facility in LA with minor interior changes, no exterior modifications, under state regulations.

Agency

California Cannabis Control, Department of

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

CA

Set-Aside

NONE

Documents

(1)

DCC NOE Peace of Green Inc Cannabis License Project

PDF•notice-of-exemption

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PostedSep 12

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyCalifornia Cannabis Control, Department of

Contacts1 person available

OfficeN/A

Organization / Agency

California Cannabis Control, Department of

Office AddressN/A

Contacts

Tia HeuEnvironmental Scientist

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

The Proposed Project will operate a Manufacturing Type 6 Non-volatile Solvent Extraction license within an existing building at 1155 E Pico Blvd., Los Angeles, CA 90021 (APN 5132-016-039). The Project will conduct non-volatile manufacturing, cultivation, retail sales, and distribution of commercial cannabis products under State and local law and improve an existing industrial building. Then Project size is comprised of one lot approximately 148 feet deep and a width of 40 feet. The site is currently developed with an existing building. The Project will include only minor interior improvements and no changes beyond existing use proposed. Water and electricity will be serviced by the City of Los Angeles.

Similar Contracts

Same NAICS industry code

Solicitation # SPE2DP-26-D-0001

The Defense Logistics Agency Troop Support is issuing a Request For Information to identify capable sources for the supply of Antidote Treatment Nerve Agent Auto-Injectors. These dual-chamber devices must be FDA licensed and capable of delivering 2.1 mg of atropine and 600 mg of pralidoxime chloride via intramuscular administration, adhering to MPID Number 6 specifications. Interested firms must provide details regarding their manufacturing location, annual capacity, FDA registration, pricing, and inventory levels. The agency is also accepting information from organizations with products currently under development, including the current stage of testing and trials. This RFI is intended for market research to inform future procurement strategies and does not constitute a formal solicitation or commitment to award a contract.

DLA Troop Support

POSTED

DEADLINE

2027 Southern Hemisphere Influenza Vaccine

Solicitation # SPE2DP26R0002

The Defense Logistics Agency Troop Support is seeking a contractor to supply approximately 30,000 doses of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. The vaccines must be FDA-approved, ACIP-recommended, and provided as pre-measured 0.5 ML doses in pre-filled syringes for intramuscular administration in individuals aged 6 months and older. The specific vaccine formula will be determined by the FDA Vaccines and Related Biological Products Advisory Committee. This is an indefinite quantity contract with a guaranteed minimum of 75 percent and a maximum of 150 percent of the annual estimate. All supplies must be delivered to the Defense Depot in New Cumberland, Pennsylvania, with a preferred completion date of March 12, 2027. Interested parties can find the solicitation on DIBBS and SAM.gov, with the primary point of contact being Rosbert Jones.

DLA Troop Support

POSTED

DEADLINE

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Solicitation # WS5872093541

Public Services and Procurement Canada, acting on behalf of the Public Health Agency of Canada, has issued an Advanced Contract Award Notice for the procurement of Vaccinia Immunoglobulin intravenous (human), known as VIGIV. This medical product is required to protect against complications arising from vaccinations with live-replicating smallpox vaccines containing the vaccinia virus. The government intends to negotiate a contract with Emergent BioSolutions Canada Inc, provided no other qualified suppliers express interest. The solicitation, identified by number WS5872093541, was posted on September 10, 2026, with a response deadline of September 30, 2026. Other potential suppliers may submit a statement of capabilities by this date to challenge the pre-identified award. The contract is managed by the Department of Public Works and Government Services for performance within Canada.

Department of Public Works and Government Services

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Typhoid Vi Polysaccharide Vaccine SupplyThis subcontract through the Defense Logistics Agency under the Department of Defense involves the supply of 1,000 units of FDA-compliant, preserved Typhoid Vi Polysaccharide Vaccine. The procurement is categorized under NAICS code 325414 and is designated for delivery to a U.S. Navy vessel. The agreement is established under FOB Destination terms, ensuring the delivery of the medical supplies to the specified naval location. The contract was posted on August 10, 2026, and is managed via the DIBBS system.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Supply and Delivery of Typhoid VI Polysaccharide Vaccine (NSN 6505015334962)This subcontract with the Defense Logistics Agency involves the procurement, packaging, and delivery of 1,000 units of preservative-free Typhoid VI Polysaccharide Vaccine. The product must comply with NDC 49281-0790-51 and NSN 6505015334962. The vaccines are to be delivered to the USS Theodore Roosevelt (CVN 71) at FPO AP 96632 by August 10, 2026. Shipping must be handled via FOB Destination using fast and traceable methods to ensure secure arrival.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

MMR Vaccine Supply and Delivery

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Pharmaceutical Product Supply – Aluminum Hydroxide Gel

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

Supply of Tetanus and Diphtheria Toxoids, Adsorbed Vaccine

Defense Logistics Agency

POSTED

about 2 months ago

DEADLINE

Biological Pharmaceutical Supply – Tetanus and Diphtheria ToxoidsThe contract pertains to the supply of FDA-approved tetanus and diphtheria toxoids, adsorbed, identified by NSN 6505016632617, specifically for delivery to a U.S. Navy vessel. This biological pharmaceutical product is procured under a subcontract by the Defense Logistics Agency on behalf of the Department of Defense, with the NAICS code 325414 indicating manufacturing of biological products. The contract was posted on August 5, 2026, and the place of performance is not specified beyond the requirement for delivery to a naval vessel, suggesting the end use is for military medical readiness. The contract is identified by the procurement number SPE2DX25D8022 and delivery identifier SPE2D926F7957, and while no set-aside type is indicated, the focus is on fulfilling a critical medical supply need for U.S. Navy operations.

Defense Logistics Agency

POSTED

about 2 months ago

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS